5Hamm CW, Bassand JP, Agewall S, et al.ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation[J].European Heart Journal,2011,32:2999-3054.
6Jeffrey LA, Cynthia DA, Elliott MA,et al. 2011ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction:A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [J]. Circulation, 2011,123:2022-2060.
7Bhatt DL,Scheiman J,Abraham NS,et al.ACCF/ACG/ AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use:a report of the American College of Cardiology FoundationTask Force on Clinical Expert Consensus Documents[J].Circulation,2008,118(18):1894-1909.
8Michelle L,Eugene B,Elliott MA,et al.Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor:an analysis of two randomised trials[J]. Lancet,2009,374(9694):989-997.
9Ho PM, Maddox TM, Wang L,et al. Risk of Adverse Outcomes Associated With Cloncomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Sydrome[J]. JAMA,2009,301(9):937-944.
